Results 131 to 140 of about 2,620 (178)

Letter to the Editor: CRISPR-based gene editing for cardiac protection in Barth syndrome. [PDF]

Ann Med Surg (Lond)
Abedin ZU, Waggan AI, Khan E, Suleman MU, Tabassum SN.   +4 more
europepmc   +1 more source

Transcriptome Analysis of Adipose Tissues from Five Sheep Breeds Reveals Key Genes Involved in Fat Deposition. [PDF]

Genes (Basel)
Yu Y, Liu S, Yang J, Xu S.
europepmc   +1 more source

Integrated multi-omics mapping of mitochondrial dysfunction and substrate preference in Barth syndrome cardiac tissue. [PDF]

EMBO Mol Med
Schomakers BV, Passadouro AS, Trętowicz MM, Simpson PJ, Jaspers YRJ, van Weeghel M, Hu IM, Lamboo CME, Cloutier D, Byrne BJ, van Klinken JB, Janssen PML, Piersma SR, Jimenez CR, Vaz FM, Salomons GS, van der Velden J, Houtkooper RH, Mosegaard S.   +18 more
europepmc   +1 more source

Cristae: bridging bioenergetic hubs and compartmental barriers in mitochondrial homeostasis. [PDF]

Cell Death Dis
Rao J, Wan QQ, Chen L, Tang RB, Killedar D, Tay F, Niu LN.   +6 more
europepmc   +1 more source

Yes-Associated Protein (YAP) Is Associated With Disease Severity and Visual Prognosis in Epiretinal Membrane. [PDF]

Invest Ophthalmol Vis Sci
Yang HS, Jo YH, Kim D, Choi S, Moon BG, Lee Y, Kim M, Koo D, Kim J.   +8 more
europepmc   +1 more source

Plaat1 deficiency reduces cardiac cardiolipin content and impairs exercise tolerance. [PDF]

J Lipid Res
Hashemi A, Liu MR, Chan JZ, Berdeklis AN, Cocco AD, Tomczewski MV, Strathdee D, Stark KD, Duncan RE.   +8 more
europepmc   +1 more source

What can ATP content tell us about Barth syndrome muscle phenotypes? [PDF]

J Transl Genet Genom
Brault JJ, Conway SJ.
europepmc   +1 more source

Unrestrained fatty acid oxidation triggers heart failure in mice via cardiolipin loss and mitochondrial dysfunction. [PDF]

J Clin Invest
Kim CW, Vale G, Fu X, McDonald JG, Dai C, Li C, Wang ZV, Sharma G, Khemtong C, Malloy CR, Deja S, Burgess SC, Mitsche MA, Horton JD.   +13 more
europepmc   +1 more source

Mitochondrial Targeting by Elamipretide Improves Myocardial Bioenergetics Without Translating into Functional Benefits in HFpEF. [PDF]

Int J Mol Sci
Schauer A, Jahn D, Vahle B, Barthel P, Männel A, Fabig G, Linke A, Adams V, Augstein A.   +8 more
europepmc   +1 more source

ABHD18 degrades cardiolipin by stepwise hydrolysis of fatty acids. [PDF]

J Biol Chem
Ren M, Chen S, Greenberg ML, Schlame M.
europepmc   +1 more source